Viewing Study NCT07260669


Ignite Creation Date: 2025-12-24 @ 10:55 PM
Ignite Modification Date: 2025-12-25 @ 8:23 PM
Study NCT ID: NCT07260669
Status: RECRUITING
Last Update Posted: 2025-12-03
First Post: 2025-09-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis
Sponsor: Gesynta Pharma AB
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module